CRA International director sells 110 shares in Rule 10b5-1 trade
A director of CRA International, Inc. reported a small sale of company stock.
Rhea-AI Filing Summary
A director of CRA International, Inc. reported a small sale of company stock. On 12/11/2025, the director sold 110 shares of common stock at a price of $198.12 per share, coded as a sale transaction ("S"). After this trade, the director beneficially owns 2,941 shares of CRA International common stock in direct ownership.
The company notes that this transaction was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025, which is designed to allow scheduled trading of shares under specified conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 110 | $198.12 | $22K |
Footnotes (1)
- F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
FAQ
What insider transaction was reported for CRA International (CRAI)?
A CRA International, Inc. director reported a sale of 110 shares of the company’s common stock in a Form 4 filing.
When did the CRAI director’s stock sale take place?
The reported sale of CRA International common stock occurred on 12/11/2025, as disclosed in the Form 4.
Was the CRA International (CRAI) trade made under a Rule 10b5-1 plan?
Yes. The filing states the transaction was effected under a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2025.
What is the relationship of the reporting person to CRA International (CRAI)?
The reporting person is identified as a director of CRA International, Inc., and is not marked as a 10% owner in the filing.
Is the Form 4 for CRA International (CRAI) filed for one or multiple insiders?
The document indicates it is a Form 4 filed by one reporting person, not by a group.
AI-generated analysis. How Rhea-AI works. Not financial advice.